A small, emerging biopharma company developing an oncology Investigational Medicinal Product (IMP) had been working with Fisher Clinical Services to blister-pack capsules in a 12-pack strip. The project was for a single protocol involving a small patient population using three different dosing strategies with a limited amount of drug product.
Within months, requirements changed multiple times, impacting the packaging process.
- Discover how a flexible solution allowed the sponsor to avoid repackaging and associated waste
- Learn how the sponsor created a solution that was scalable through all phases of the trial